News – Page 971 – Endpoints News

Backed by OrbiMed, Lilly and now Advantech, China's InventisBio loads up $70M to propel cancer, metabolic pipeline

7 years ago

Neurocrine breaks out proof-of-concept data for CAH drug; Akebia, MTPC work toward Japanese NDA after anemia drug ...

7 years ago

GeNeuro touts a mixed set of extension data in a shot at salvaging their failed mid-stage MS drug

7 years ago

With Alimta patent cliff looming, Lilly plots stronger foothold in frontline NSCLC with Cyramza

7 years ago

Biotech execs predict big M&A deals ahead as mood shifts in wake of a 2018 hangover — Endpoints 100

7 years ago

Trump's White House proposes raft of cuts to science R&D budgets, but FDA scores higher funds

7 years ago

FDA offers quick thumbs up to expand Dupixent's atopic dermatitis label as Regeneron/Sanofi plot blockbuster moves

7 years ago

EMA launches operations in Amsterdam

7 years ago

AstraZeneca lines up a $20M installment plan to launch a new oncology collaboration with microbiome player Seres

7 years ago

Zafgen's second try at Prader-Willi syndrome triggers another safety alarm in preclinical tox study

7 years ago

Is second time the charm for ozanimod? Celgene starts to find out with EMA filing

7 years ago

Takeda touts a landmark head-to-head PhIIIb win over Humira; Allergan's oral CGRP is now under FDA review

7 years ago

Principia, AbbVie walk away from 2017 partnership for inflammatory, autoimmune drugs

7 years ago

Two big pharma execs share the same challenges, but compensation? They’re not even close

7 years ago

It’s what Bristol-Myers execs aren’t saying that makes one key analyst wonder about a potential buyout offer, ...

7 years ago

Roche claims a first in breast cancer as Tecentriq/Abraxane combo nabs quick approval in frontline use

7 years ago

Early data snapshots of Axovant's gene therapies for Parkinson's, Tay Sachs appear promising

7 years ago

Lundbeck fund backs a $50M launch round for SNIPR Biome, a new brand of CRISPR Cas biotech

7 years ago

Prison officials launch a probe into Martin Shkreli's latest antics, allegedly running his biotech business with a ...

7 years ago

Merck gives King's College London, Wellcome Trust up to $340M in deal to develop non-opioid painkillers

7 years ago

From Agios to Deciphera, Steve Hoerter plots another oncology launch; Roche exec Christiane Hamachar moves to India ...

7 years ago

Dupixent scores speedy review for rhinosinusitis with nasal polyps; After transplant, third patient is HIV-free for 3 ...

7 years ago

Years after it was OK'd, AMAG's drug for preventing preterm births fails badly in long-awaited confirmatory trial

7 years ago

FDA experts gun down a big part of Sanofi's pitch for their controversial vaccine

7 years ago

First page Previous page 968 969 970971972 973 974 Next page Last page